The 23 analysts offering 12-month price forecasts for Gilead Sciences Inc have a median target of 74.80, with a high estimate of 100.00 and a low estimate of 61.00. The median estimate represents a +8.39% increase from the last price of 69.01.
The current consensus among 29 polled investment analysts is to Hold stock in Gilead Sciences Inc. This rating has held steady since June, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.74
Reporting Date Jul 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.